
US Inflation Below 5% - Pre Market Analysis
Pre-market analysis: US inflation drops below 5% for the first time in 25 months. Get updates on NIFTY, BANK NIFTY, and corporate earnings.
Markets, money and investing, explained without the jargon.

Pre-market analysis: US inflation drops below 5% for the first time in 25 months. Get updates on NIFTY, BANK NIFTY, and corporate earnings.

Dr Reddy’s Labs reports 890% profit jump in Q4 FY23. Get the latest Indian market updates, including Q4 results for L&T, Godrej Consumer, and IPO news.

Bank Nifty saw an 1100-point intraday movement, closing at 43,331. Nifty reclaimed 18,300, closing at 18,315. Read the post-market analysis.

Pre-market analysis on US inflation, corporate earnings, and market movements for NIFTY, BANK NIFTY, and FIN NIFTY. Get key support and resistance levels.

Apollo Tyres reports a 277% YoY jump in Q4 net profit to Rs 427 crore. Also, Adani Ports to prepay $130M debt, Nazara Tech profit rises 18%.

NIFTY and BANK NIFTY closed flat today. NIFTY up 0.01%, BANK NIFTY down 0.2%. US CPI data awaited. Read the full post-market analysis.

Get the latest pre-market analysis including Q4 results for major companies, NIFTY, BANK NIFTY, and FIN NIFTY movements, support/resistance levels, and FII/DII data.

Coal India's Q4 net profit fell 18% YoY to Rs 5,528 crore. Canara Bank's net profit rose 90% YoY to Rs 3,175 crore. Happiest Minds, UPL also report results.

Nifty closed at 18,264, up 1.08%, with Auto stocks leading gains. Bank Nifty also rose. FIIs were net buyers for 7 sessions.

Get today's pre-market analysis with major updates, company results from Olectra Greentech and Alembic Pharma, and NIFTY/BANK NIFTY support/resistance levels.

NIFTY, BANK NIFTY, and FIN NIFTY movements for the second week of May. Key events include corporate results, India's inflation report, and US inflation data.

Britannia's net profit rose 47% YoY to Rs 559 crore in Q4 FY23. Also, India's forex reserves increased, Federal Bank's profit jumped 67%, and Dr. Reddy's launched a new injection in the US market.